Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVENT: Early Tirofiban Administration After IVT in Acute Ischemic Stroke
NCT06045156Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Apr 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tirofiban in ischemic stroke (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Proportion of patients with modified Rankin Scale (mRS) score 0-1 at 90 days. Started Apr 2024; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06045156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06045156.